Black Diamond Therapeutics Inc (BDTX) — Cash Flow Quality Index
Black Diamond Therapeutics Inc (BDTX) has a Cash Flow Quality Index of 0.94x as of March 2025. Operating cash flow of $53.41 Million is below net income of $56.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Black Diamond Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Black Diamond Therapeutics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Black Diamond Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BDTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Black Diamond Therapeutics Inc (2025–2025)
Year-by-year earnings quality comparison for Black Diamond Therapeutics Inc. For live market cap and the full company financial profile, see BDTX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.32x | $29.61 Million | $22.37 Million | — |